BUB3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.903800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.703800E-01
Normal-vs-Stage2
9.697200E-01
Normal-vs-Stage3
4.663000E-01
Normal-vs-Stage4
9.886400E-01
Stage1-vs-Stage2
8.988200E-01
Stage1-vs-Stage3
4.757600E-01
Stage1-vs-Stage4
9.590400E-01
Stage2-vs-Stage3
2.319200E-01
Stage2-vs-Stage4
9.897200E-01
Stage3-vs-Stage4
5.431600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.778200E-01
Normal-vs-AfricanAmerican
9.157200E-01
Normal-vs-Asian
9.512400E-01
Caucasian-vs-AfricanAmerican
9.395200E-01
Caucasian-vs-Asian
8.828000E-01
AfricanAmerican-vs-Asian
8.074600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.605600E-01
Normal-vs-Female
9.807000E-01
Male-vs-Female
7.860800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.918600E-01
Normal-vs-Age(41-60Yrs)
7.860600E-01
Normal-vs-Age(61-80Yrs)
8.981800E-01
Normal-vs-Age(81-100Yrs)
7.285400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.149550E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.907400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.479850E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.622760E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.425800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.248600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.917000E-01
Normal-vs-Daily Drinker
9.583800E-01
Normal-vs-Weekly Drinker
7.592600E-01
Normal-vs-Occasional Drinker
7.186200E-01
Normal-vs-Social Drinker
6.967800E-01
Non Drinker-vs-Daily Drinker
8.796400E-01
Non Drinker-vs-Weekly Drinker
4.256000E-01
Non Drinker-vs-Occasional Drinker
3.252200E-01
Non Drinker-vs-Social Drinker
7.546400E-01
Daily Drinker-vs-Weekly Drinker
4.921800E-01
Daily Drinker-vs-Occasional Drinker
4.747800E-01
Daily Drinker-vs-Social Drinker
6.500400E-01
Weekly Drinker-vs-Occasional Drinker
7.794400E-01
Weekly Drinker-vs-Social Drinker
3.342200E-01
Occasional Drinker-vs-Social Drinker
1.754970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.433200E-01
Normal-vs-Grade 2
1.333440E-01
Normal-vs-Grade 3
8.235700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.164000E-02
Grade 1-vs-Grade 3
4.297400E-03
Grade 1-vs-Grade 4
3.433200E-01
Grade 2-vs-Grade 3
3.839600E-01
Grade 2-vs-Grade 4
1.333440E-01
Grade 3-vs-Grade 4
8.235700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.510600E-01
Normal-vs-NonDiabetic
9.703600E-01
Diabetic-vs-NonDiabetic
3.098600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.575200E-01
Normal-vs-NoPancreatitis
9.856200E-01
Pancreatitis-vs-NoPancreatitis
9.607400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.943600E-01
Normal-vs-N1
9.940000E-01
N0-vs-N1
6.980800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.722600E-01
Normal-vs-TP53-NonMutant
8.927400E-01
TP53-Mutant-vs-TP53-NonMutant
2.958300E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
